Jane Street
TCRT icon

Jane Street’s Alaunos Therapeutics TCRT Stock Holding History

Jane Street’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,055
Closed -$272K – 10134
2022
Q3 		$272K Buy
+1,055
New +$306K ﹤0.01% 7742
2021
Q4 		– Sell
-114
Closed -$31K – 10802
2021
Q3 		$31K Sell
114
-297
-72% -$90.8K ﹤0.01% 9672
2021
Q2 		$163K Sell
411
-172
-30% -$80.3K ﹤0.01% 8977
2021
Q1 		$315K Buy
+583
New +$363K ﹤0.01% 7631
2017
Q3 		– Sell
-71
Closed -$66K – 5050
2017
Q2 		$66K Buy
+71
New +$69.6K ﹤0.01% 4210
2017
Q1 		– Sell
-144
Closed -$116K – 4668
2016
Q4 		$116K Buy
+144
New +$130K ﹤0.01% 3845
2016
Q3 		– Sell
-89
Closed -$74K – 4520
2016
Q2 		$74K Buy
+89
New +$96.9K ﹤0.01% 3926
2016
Q1 		– Sell
-183
Closed -$228K – 4625
2015
Q4 		$228K Buy
+183
New +$303K ﹤0.01% 3427
2015
Q3 		– Sell
-135
Closed -$244K – 4130
2015
Q2 		$244K Sell
135
-1,077
-89% -$1.67M ﹤0.01% 3056
2015
Q1 		$1.96M Buy
+1,212
New +$1.8M 0.02% 877

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street's TCRT Position: Q4 2023 in Review

Jane Street sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 84 shares — an estimated $1.67K sold.

Jane Street first reported a position in TCRT in Q2 2013 and held it in 30 quarters. The position peaked at $1.51M in Q2 2015. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

  • Jane Street reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Jane Street sold 84 Alaunos Therapeutics shares in Q4 2023, an estimated $1.67K.
  • Jane Street first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 30 quarters.
  • Jane Street's Alaunos Therapeutics position peaked at $1.51M in Q2 2015.
  • 82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.